FCGR1A and cholangiocarcinoma: For instance, Huang et al. identified CD247 from TCGA and GEO databases, and Fc gamma receptor Ia (FCGR1A) and transformation/transcription domain associated protein (TRRAP) were used as potential therapeutic targets for the treatment of cholangiocarcinoma [3].